Suncoast Equity Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
13,288
+535
| +4% | +$41.8K | 0.11% | 52 |
|
|
2025
Q1 | $924K | Buy |
12,753
+1,860
| +17% | +$135K | 0.1% | 51 |
|
|
2024
Q4 | $806K | Buy |
10,893
+1,388
| +15% | +$103K | 0.09% | 45 |
|
|
2024
Q3 | $627K | Buy |
9,505
+31
| +0.3% | +$2.05K | 0.07% | 54 |
|
|
2024
Q2 | $875K | Buy |
9,474
+589
| +7% | +$54.4K | 0.1% | 45 |
|
|
2024
Q1 | $849K | Buy |
8,885
+420
| +5% | +$40.1K | 0.1% | 45 |
|
|
2023
Q4 | $645K | Buy |
8,465
+15
| +0.2% | +$1.14K | 0.09% | 48 |
|
|
2023
Q3 | $585K | Buy |
8,450
+295
| +4% | +$20.4K | 0.09% | 46 |
|
|
2023
Q2 | $769K | Buy |
8,155
+32
| +0.4% | +$3.02K | 0.12% | 39 |
|
|
2023
Q1 | $672K | Buy |
8,123
+888
| +12% | +$73.5K | 0.11% | 36 |
|
|
2022
Q4 | $540K | Buy |
7,235
+340
| +5% | +$25.4K | 0.1% | 37 |
|
|
2022
Q3 | $570K | Sell |
6,895
-950
| -12% | -$78.5K | 0.11% | 32 |
|
|
2022
Q2 | $746K | Buy |
7,845
+315
| +4% | +$30K | 0.13% | 30 |
|
|
2022
Q1 | $886K | Buy |
7,530
+4,670
| +163% | +$549K | 0.13% | 31 |
|
|
2021
Q4 | $371K | Buy |
2,860
+205
| +8% | +$26.6K | 0.05% | 36 |
|
|
2021
Q3 | $301K | Buy |
2,655
+385
| +17% | +$43.6K | 0.04% | 37 |
|
|
2021
Q2 | $235K | Buy |
+2,270
| New | +$235K | 0.03% | 45 |
|
|
2021
Q1 | – | Sell |
-2,270
| Closed | -$207K | – | 45 |
|
|
2020
Q4 | $207K | Buy |
+2,270
| New | +$207K | 0.03% | 46 |
|
|
2020
Q1 | – | Sell |
-3,300
| Closed | -$257K | – | 45 |
|
|
2019
Q4 | $257K | Buy |
+3,300
| New | +$257K | 0.05% | 43 |
|